Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Supreme Court asks Centre to respond on clinical trial of vaccines - The Pharma Times | Pharma & Health Care News Portal

Supreme Court asks Centre to respond on clinical trial of vaccines

New Delhi, Jan 19, 2015 : Supreme Court on Tuesday asked the Centre to file its response giving details like process of taking consent of persons on whom clinical trial of cervical cancer prevention vaccines, Gardasil and Cervarix, have been carried out.

A bench of justices Dipak Misra and Prafulla C Pant asked the Centre to also indicate who would be liable to pay compensation to the persons if the clinical trial of the vaccination caused adverse impact.

Besides the Centre, the bench also asked governments of Gujarat, Andhra Pradesh and Telangana, where clinical trials of the vaccines have taken place, to file their responses within four weeks about issues including the number of affected persons.

The bench asked the Centre to keep in view the 81st report of the Parliamentary Standing Committee on clinical trial of vaccines while filing its response.

During the hearing, the counsel for Gujarat said seven deaths were reported from the state and moreover, these did not happen due to the clinical trials but were rather caused by reasons including snake bites.

The court, however, did not concur with the submission. Earlier, the court had asked the Centre to place before it the records regarding the licenses given to cervical cancer prevention vaccines, Gardasil and Cervarix.

It had directed the Centre to place before it the report of Parliamentary Standing Committee on Health and Family Welfare which has dealt with the issue of drugs relating to Human Papilloma Virus ( HPV) vaccine.

The court had allowed to make Gujarat, Andhra Pradesh and Telangana as respondents in the matter as some villages in these states were chosen for administering the vaccine as an experiment and reports had allegedly suggested that girls suffered side effects of Gardasil and Cervarix, manufactured by pharmaceuticals major Merck Sharpe and Dohme respectively.

The bench said it had to examine whether proper protocol and procedure was followed for introduction of these vaccines because it has been alleged that deaths have also been caused due to the situation. PTI

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

6 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

1 week ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago